Shanxi Jin Huahui star Pharmacy, Datong pharmaceutical Industry and other enterprises capsules are exposed to excessive chromium

Shanxi Province Food and Drug Administration 25th notified Shanxi Province capsule drug supervision and sampling situation, 30 batches of products unqualified. Chromium over the medical capsule after the incident, in accordance with the unified deployment of the National Bureau, the Food and Drug Administration of Shanxi province to 70 in the production of capsules pharmaceutical manufacturers conducted a full coverage of the supervision and testing, a total of 246 batches of drug-testing capsules, 216 batches of qualified products, unqualified products 30 batches. The Food and Drug Administration of Shanxi Province said that the Chinese Pharmacopoeia 2010 version before the implementation of the production of capsule drugs chromium content of the excess of the active recall by the production enterprises, not administrative penalties. Individual batches of chromium products are undergoing retest, retest results such as inconsistent with the results of the release, to retest after the results of the publication shall prevail. Chromium content exceeding product Lot list Production Enterprise name product lot number remark Shanxi Thousand Hui Pharmaceutical Co., Ltd. huangmin capsule 110804 Datong Yun Gang Pharmaceutical Co., Ltd. indomethacin capsules 111206 linfen Pearl Pharmaceutical Co., Ltd. Licorice Zinc Capsules 110801 Shanxi De Yuandong Pharmaceutical Co., Ltd. Liver Joy capsules 11001107625 Shanxi Fenhe Pharmaceutical Co., Ltd. people 1108561 Shanxi Hou Machine Pharmaceutical Co., Ltd. Hericium Jianwei Ling capsule 20110530 Shanxi Hou Machine Pharmaceutical Co., Ltd. Hericium Jianwei Ling capsule 20110908 Shanxi Yellow River Medicine Co., Ltd. more than 20100101 Chinese Pharmacopoeia 2010 version before the implementation of the production of Shanxi Jin Huahui Star Pharmaceutical Co., Ltd. flunarizine hydrochloride capsules 09060 9 China Pharmacopoeia 2010 version before the implementation of the production of Shanxi Tong da Pharmaceutical Co., Ltd. norfloxacin capsules 110504 Shanxi Tong da Pharmaceutical Co., Ltd. wei u belladonna aluminum capsule ⅱ110701 Shanxi Wang Long Pharmaceutical Co., Ltd. Hericium Jianwei Ling capsule 20111102 Shanxi Wang Long Pharmaceutical Co., Ltd. Ammonia-Huangmin capsules 20110402 Shanxi Wang Long Pharmaceutical Co., Ltd. Antelope Cold Capsules 20101 201 Shanxi Xinxing Pharmaceutical Co., Ltd. u belladonna Aluminum capsule ⅲ20110503 Datong Pharmaceutical Co., Ltd. Indomethacin Capsules 111001 NOTE: 1, the Chinese Pharmacopoeia 2010 version before the implementation of the capsule drug chromium content exceeded the active recall by the production enterprises, not administrative punishment. 2, individual batches of chromium products are retest, retest results such as inconsistent with the results of the release, to retest after the results of the release shall prevail.